Longitudinal dynamic changes in factor VIII inhibitor titers in patients with hemophilia A and inhibitors receiving emicizumab prophylaxis

Emicizumab prophylaxis dramatically reduces bleeding events in patients with hemophilia A (PwHA) with or without factor VIII (FVIII) inhibitors. However, long-term dynamic changes in FVIII inhibitor titers during emicizumab prophylaxis remain to be investigated. We conducted a retrospective follow-u...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	International journal of hematology 2023-12, Vol.118 (6), p.690-698
Hauptverfasser:	Shimonishi, Naruto, Sasai, Kana, Ogiwara, Kenichi, Furukawa, Shoko, Nakajima, Yuto, Mizumachi, Kuniyoshi, Yada, Koji, Takeyama, Masahiro, Shima, Midori, Mizuno, Narumi, Nogami, Keiji
Format:	Artikel
Sprache:	eng
Schlagworte:	Coagulation factors Disease prevention Hematology Hemophilia Inhibitors Medicine Medicine & Public Health Monoclonal antibodies Oncology Original Article Prophylaxis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!